Metabolic Bone Articles & Analysis: Older
3 articles found
Biotech company Nuritas speeds up ingredient discovery in nutrition through AI, using techniques from the pharmaceutical industry where innovation and investment rates are much higher. Through its bioactive peptide finder, Magnifier NπΦ, the company can boast a clinical trial success rate of 80%. Development of an ingredient goes through three phases, from discovery to preclinical biology ...
Alexander Kupferthaler, Interventional Radiologist at the Ordensklinikum Linz – Barmherzige Schwestern, for a robot-guided bone biopsy. Clinical Context 65-year-old female with invasive lobular carcinoma of the breast with skeletal carcinomatosis. After years of progression-free survival, a PET-CT scan detected several novel, abnormal metabolic ...
The ratio of Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Osteoprotegerin (OPG) has become an important marker to assess the status of systemic bone metabolism and has been shown to be dysregulated in AS patients. ...